NDC 0641-6264
Neostigmine Methylsulfate 0.5 mg per 1 mL injection
On the label: Hikma Pharmaceuticals USA Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | Cherry Hill, NJ, United States | Makes it, tests it, packages it and labels it | No problems foundMay 13, 2026 · 18 inspections |
Product details
- Generic drug
- Neostigmine: every company that makes it
- Form
- injection, intravenous
- Strength
- 0.5 mg per 1 mL
- Approval
- ANDA ANDA207042
- On the market since
- Dec 28, 2015
- Package NDCs
0641-6264-010641-6264-10- Official label
- DailyMed (National Library of Medicine), updated Apr 10, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?